HWP
TEVA icon

Hefty Wealth Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Hefty Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-149
Closed -$3K – 264
2017
Q3 		$3K Hold
149
– – ﹤0.01% 231
2017
Q2 		$4K Hold
149
– – ﹤0.01% 206
2017
Q1 		$4K Hold
149
– – ﹤0.01% 207
2016
Q4 		$5K Hold
149
– – ﹤0.01% 194
2016
Q3 		$6K Hold
149
– – ﹤0.01% 191
2016
Q2 		$7K Hold
149
– – 0.01% 159
2016
Q1 		$7K Hold
149
– – 0.01% 164
2015
Q4 		$9K Buy
+149
New +$9.21K 0.01% 144

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Hefty Wealth Partners's TEVA Position: Q4 2017 in Review

Hefty Wealth Partners sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 149 shares — an estimated $3K sold.

Hefty Wealth Partners first reported a position in TEVA in Q4 2015 and held it in 8 quarters. The position peaked at $9K in Q4 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Hefty Wealth Partners reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Hefty Wealth Partners sold 149 Teva Pharmaceuticals shares in Q4 2017, an estimated $3K.
  • Hefty Wealth Partners first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 8 quarters.
  • Hefty Wealth Partners's Teva Pharmaceuticals position peaked at $9K in Q4 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Hefty Wealth Partners's 13F filing for Q4 2017, filed 3 Jan 2018.